Invesco Ltd. Neogenomics Inc Transaction History
Invesco Ltd.
- $503 Billion
- Q1 2025
A detailed history of Invesco Ltd. transactions in Neogenomics Inc stock. As of the latest transaction made, Invesco Ltd. holds 433,163 shares of NEO stock, worth $3.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
433,163
Previous 410,967
5.4%
Holding current value
$3.04 Million
Previous $6.77 Million
39.31%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding NEO
# of Institutions
288Shares Held
127MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$138 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$99.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$47.1 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$42.4 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$40.2 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $882M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...